Association of c-Met phosphorylation with micropapillary pattern and small cluster invasion in pT1-size lung

Kaori Koga1, Makoto Hamasaki, Fumiaki Kato

  • 1Department of Pathology, Fukuoka University Hospital and School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.

Insights

Micropapillary pattern in lung adenocarcinoma is linked to metastasis. This study suggests that activated c-Met signaling drives this process, potentially impacting patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • Lung adenocarcinomas with micropapillary pattern (MPP) frequently metastasize to lymph nodes.
  • The underlying mechanisms of MPP-associated metastasis, particularly small cluster invasion (SCI), remain unclear.
  • The c-Met pathway is implicated in tumor cell motility and invasion.

Purpose of the Study:

  • To investigate the role of c-Met activation in the sequence of MPP and SCI in lung adenocarcinoma.
  • To correlate phosphorylated c-Met (pc-Met) expression with MPP, SCI, lymphatic involvement, and prognosis in pT1 lung adenocarcinomas.

Main Methods:

  • Immunohistochemical analysis of phosphorylated c-Met (pc-Met) in 125 pT1 lung adenocarcinomas.
  • Correlation of pc-Met expression with clinicopathological features including MPP, SCI, lymphatic involvement, and nodal metastasis.
  • Survival analysis in relation to pc-Met expression levels.

Main Results:

  • SCI was significantly more frequent in MPP-positive tumors and associated with lymphatic involvement and nodal metastasis.
  • High pc-Met expression strongly correlated with MPP and SCI.
  • In tumors with MPP or SCI, high pc-Met levels were linked to increased lymphatic involvement.
  • High pc-Met expression predicted worse survival in Stage IA lung adenocarcinoma patients.

Conclusions:

  • Activation of the c-Met pathway, indicated by high pc-Met expression, is associated with MPP and SCI in lung adenocarcinoma.
  • The c-Met pathway may play a critical role in the progression and metastasis of lung adenocarcinomas with MPP.
  • Targeting the c-Met pathway could be a potential therapeutic strategy for these tumors.